Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 595

[100] Pean JM, Boury F, Venier-Julienne MC, Menei P, Proust JE, Benoit JP. Why does PEG
400 co-encapsulation improve NGF stability and release from PLGA biodegradable
microspheres? Pharm Res 1999;16:1294-9.
[101] Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhy-
dride microspheres. Pharm Res 1993;10:487-96.
[102] Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using
biodegradable poly(D,L-lactide- co -glycolide): protein stability and the effects of stabi-
lizing excipients. Eur J Pharm Biopharm 1997;43:29-36.
[103] Jiang W, Schwendeman SP. Stabilization of a model formalinized protein anti-
gen encapsulated in poly(lactide- co -glycolide)-based microspheres. J Pharm Sci
2001;90:1558-69.
[104] Zhu G, Schwendeman SP. Influence of basic salts on stability and release of proteins in
injectable poly(lactide- co -glycolide) delivery devices. Proc Int Symp Control Release
Bioact Mater 1999;26:1112-3.
[105] Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics,
stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactdide-
co -glycolide) microspheres. J Control Release 2002;79:137-45.
[106] Park TG, Lee HY, Nam YS. A new preparation method for protein loaded poly(D,L-
lactic- co -glycolic acid) microspheres and protein release mechanism study. J Control
Release 1998;55:181-91.
[107] Fu K, Griebenow K, Hsieh L, Klibanov AM, Langer R. FTIR characterization of the
secondary structure of proteins encapsulated within PLGA microspheres. J Control
Release 1999;58:357-66.
[108] Cleland JL, Jones AJ. Stable formulations of recombinant human growth hormone
and interferon- for microencapsulation in biodegradable microspheres. Pharm Res
1996;13:1464-75.
[109] Kang F, Jiang G, Hinderliter A, DeLuca PP, Singh J. Lysozyme stability in primary
emulsion for PLGA microsphere preparation: effect of recovery methods and stabiliz-
ing excipients. Pharm Res 2002;19:629-33.
[110] Perez C, De Jesus P, Griebenow K. Preservation of lysozyme structure and function
upon encapsulation and release from poly(lactic- co -glycolic) acid microspheres pre-
pared by the water in-oil-in-water method. Int J Pharm 2002;248:193-206.
[111] Perez-Rodriguez C, Montano N, Gonzalez K, Griebenow K. Stabilization of -chymo-
trypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in
PLGA microspheres. J Control Release 2003;89:71-85.
[112] Carrasquillo KG, Stanley AM, Aponte-Carro JC, De Jesus P, Costantino HR, Bosques
CJ, et al. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA
into poly(lactide- co -glycolide) microspheres results in release of native protein.
J Control Release 2001;76:199-208.
[113] Samra HS, He F, Bhambhani A, Pipkin JD, Zimmerer R, Joshi SB, et al. The effects of
substituted cyclodextrins on the colloidal and conformational stability of selected pro-
teins. J Pharm Sci 2010;9:2800-18.
[114] Liu Y, Zhang YM, Qi AD, Chen RT, Yamamoto K, Wada T, et al. Molecular recog-
nition study on a supramolecular system inclusion complexation of modified ß-cyclo-
dextrins with amino acids: enhanced enantioselectivity for L/D-leucine. J Org Chem
1997;62:1826-30.
[115] Matsubara K, Irie T, Uekama K. Spectroscopic characterization of the inclusion com-
plex of a luteinizing hormone releasing hormone agonist, buserelin acetate, with
dimethyl--cyclodextrin. Chem Pharm Bull 1997;45:378-83.